A detailed history of New York State Common Retirement Fund transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 3,622 shares of PRLD stock, worth $3,766. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,622
Previous 19,122 81.06%
Holding current value
$3,766
Previous $73,000 90.41%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$2.07 - $6.37 $32,084 - $98,735
-15,500 Reduced 81.06%
3,622 $7,000
Q2 2024

Jul 31, 2024

SELL
$3.32 - $5.63 $3,320 - $5,630
-1,000 Reduced 4.97%
19,122 $73,000
Q4 2023

Feb 01, 2024

SELL
$1.69 - $4.37 $45 - $117
-27 Reduced 0.13%
20,122 $86,000
Q3 2023

Nov 07, 2023

BUY
$2.74 - $4.79 $408 - $713
149 Added 0.75%
20,149 $62,000
Q2 2023

Aug 07, 2023

BUY
$4.45 - $8.12 $89,000 - $162,399
20,000 New
20,000 $90,000
Q2 2022

Aug 04, 2022

SELL
$4.0 - $7.55 $19,600 - $36,995
-4,900 Reduced 98.16%
92 $0
Q1 2022

May 05, 2022

SELL
$6.9 - $13.22 $28,290 - $54,202
-4,100 Reduced 45.09%
4,992 $34,000
Q4 2021

Feb 02, 2022

SELL
$11.89 - $31.74 $202 - $539
-17 Reduced 0.19%
9,092 $113,000
Q3 2021

Nov 02, 2021

BUY
$25.78 - $38.65 $876 - $1,314
34 Added 0.37%
9,109 $285,000
Q2 2021

Aug 02, 2021

BUY
$28.63 - $44.3 $2,147 - $3,322
75 Added 0.83%
9,075 $260,000
Q1 2021

May 11, 2021

BUY
$39.27 - $91.68 $70,686 - $165,024
1,800 Added 25.0%
9,000 $390,000
Q4 2020

Feb 08, 2021

BUY
$28.81 - $88.94 $207,432 - $640,368
7,200 New
7,200 $515,000

Others Institutions Holding PRLD

About Prelude Therapeutics Inc


  • Ticker PRLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,369,200
  • Market Cap $37.8M
  • Description
  • Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...
More about PRLD
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.